Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
59,989,847
-
Share change
-
+15,656,488
-
Total reported value
-
$28,137,178
-
Price per share
-
$0.47
-
Number of holders
-
46
-
Value change
-
+$7,237,504
-
Number of buys
-
24
-
Number of sells
-
12
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q3 2023
As of 30 Sep 2023,
RECRO PHARMA INC - COM (SCTL) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,989,847 shares.
The largest 10 holders included
First Light Asset Management, LLC, AWM Investment Company, Inc., Samjo Capital LLC, Driehaus Capital Management LLC, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, Caligan Partners LP, First Eagle Investment Management, LLC, Alyeska Investment Group, L.P., and Nantahala Capital Management, LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.